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The establishment of pluripotent stem cell lines from explanted testes has been hampered by a poor under-
standingof their cellular origin. In this issueofCell StemCell, Ko et al. (2009) reproducibly generate pluripotent
cell lines from murine testes and unequivocally demonstrate their origin from spermatogonial stem cells.Pluripotent cell lines can be established
from different sources, including embry-
onic stem cells (ESCs) from blastocyst-
stage embryos, embryonic germ cells
(EGCs) from primordial germ cells (PGCs),
and induced pluripotent stem cells
(iPSCs) from somatic cells upon overex-
pression of defined transcription factors
(Hochedlinger and Plath, 2009). In addi-
tion, several groups have succeeded in
deriving ESC-like cells from explanted
murine and human testis cells (Conrad
et al., 2008; Guan et al., 2006; Kanatsu-
Shinohara et al., 2004, 2008; Kossack
et al., 2008; Seandel et al., 2007).
However, due to the low derivation effi-
ciency of ESC-like cells from testes, and
the lack of robust derivation protocols,
the precise cellular origin of testis-derived
pluripotent cells remained elusive. A func-
tional and molecular comparison of the
reported cell lines could not conclusively
ascertain whether they originated from
rare, residual PGCs, or rather from more
committed spermatogonial stem cells
(SSCs). In this issue of Cell Stem Cell, Ko
et al. (2009) use clonal analyses to demon-
strate that germline-derived pluripotent
stem (gPS) cells arise from unipotent
SSCs. In addition, the authors define
specific culture parameters to consis-
tently induce the switch from unipotent
to pluripotent cells.
Robust Derivation of Pluripotent
Cells from Adult Testis
In their study, Ko et al. cultured single
Oct4-expressing,c-kit-negative testiscells
isolated from an Oct4-GFP reporter
mouse and derived stable SSC lines at
a frequencyof0.6%. Importantly, the re-
sulting, cultured SSCs restore spermato-
genesis upon transplantation into thetestes of infertile mice, confirming their
germline properties. Furthermore, when
seeded at low plating densities, SSC
cultures gave rise to spontaneous gPS
cell colonies at a reproducible frequency
of0.01% within 4 weeks. gPS cells were
able to generate low-degree chimeras
capable of germline transmission (Table
1), thus fulfilling all the requirements for
a bona fide pluripotent cell type.
Prior to the present report from Scho¨ler
andcolleagues (Koetal., 2009), thecellular
origin of gPS cells remained controversial.
Previously, Seandel et al. attempted to
address this question by demonstrating
that rare pluripotent cell clusters emerged
spontaneously within long-term cultured
(3 months) SSCs (Seandel et al., 2007).
However, the presence of a rare contami-
nating pluripotent cell type could not be
excluded in this setting. In a separate
study, Kanatsu-Shinohara and colleagues
derived a pluripotent line that carried an
apparently identical transgenic integration
pattern as a starting SSC line. However,
the possibility of rare identical integration
events in two unrelated cells could not be
formally excluded. An important advance
of the current study is the demonstration
that SSC lines can be established from
single Oct4+c-kit GSCs, and that gPS
cells can be clonally derived from SSC
lines, thus providing unequivocal evidence
that unipotent SSCs are the cells of origin
for pluripotent cells (Ko et al., 2009).
Characteristics of Testis-Derived
Pluripotent Cells
In their seminal report demonstrating
the derivation of so-called multipotent
germline stem cells (mGSCs) from
neonatal testes, Kanatsu-Shinohara and
colleagues used unfractionated testesCell Stecells and selected reprogrammed colo-
nies solely on the basis of their ESC
morphology (Kanatsu-Shinohara et al.,
2004) (Table 1). mGSCs formed differenti-
ated teratomas and supported the devel-
opment of chimeric mice. However, this
methodology did not allow the derivation
of mGSCs from adult mice unless p53-
deficient animals were used, which are
more prone to develop teratocarcinoma.
Neonatally derived mGSCs exhibited
a genomic imprint pattern reminiscent
of PGCs with largely erased imprints
and some male-specific (androgenetic)
imprints. Because imprinted DNA methyl-
ation marks are thought to be established
around birth, it is likely that mGSCs were
derived from relatively primitive germ cells
that had not yet fully established their
androgenetic imprints. Alternatively, the
derivation procedure for mGSCs itself
could have resulted in the erasure of
some of the imprints, as is often seen in
cultured ESCs. The current report revisits
this issue and finds that male-specific
imprints are maintained following con-
version into gPS cells, suggesting that
gPS cells may originate from a different
type of germ cell than mGSCs (Ko et al.,
2009).Sinceunbalancedgenomic imprint-
ing can result in tumor formation in mice,
caution is warranted in a potential thera-
peutic application of human germ-cell-
derived pluripotent cells.
The observation that genomic im-
printing appears conserved in adult
germ-cell-derived pluripotent cells raises
questions about the origin of the previ-
ously reported multipotent adult germline
stem cells (maGSCs) derived from the
testes of a Stra8-GFP reporter mouse
(Guan et al., 2006) (Table 1). In contrast
to adult SSCs and gPS cells, maGSCsm Cell 5, July 2, 2009 ª2009 Elsevier Inc. 3
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PreviewsTable 1. Summary of Reports of Murine Testis-Derived Pluripotent Cell Lines
Kanatsu-Shinohara et al., 2004 Seandel et al., 2007 Guan et al., 2006 Ko et al., 2009








Age of donor mouse neonates or p53-deficient
adult mice
up to 1 year of age 4–6 weeks 5–8 weeks
Strain of mice ddY and DBA/2 various strains 129/Ola, C57Bl/6, FVB 129Sv, C57Bl/6, FVB
Pluripotent cell line mGSCs MASCs maGSCs gPS cells
Conversion frequency 1 in 107 testis cells (0.00001%) ND 4 lines from 15 mice 0.01%
Chimeras (stage) adult midgestation adult adult
Germline transmission yes (by ICSI) ND yes (by PCR and lacZ) yes (by PCR)
Imprint status erased imprints with partially
re-established androgenetic pattern
ND somatic androgenetic
Gene expression pattern epiblast-like epiblast-like ESC-like? ESC-like
ND, not determined; ICSI, intracytoplasmic sperm injection.displayed a somatic imprinting pattern.
Another difference compared with the
other studies is the observation that
Stra8-GFP mGSCs have the ability to
both restore spermatogenesis upon trans-
plantation into testes and form teratomas
and chimeras upon injection into immuno-
compromised mice and blastocysts,
respectively. This is a puzzling result, as
testicular engraftment and teratoma/
chimera-forming potential are usually
mutually exclusive properties. Clearly,
further work is needed to resolve the
apparent discrepancies between the
various studies.
Seandel and coworkers used an alter-
native spermatogonial marker, GPR125,
to identify a population of germ cells that
can give rise to multipotent adult sper-
matogonial-derived stem cells (MASCs)
(Seandel et al., 2007) (Table 1). MASCs
exhibited multilineage differentiation po-
tential in vitro and in the context of tera-
tomas and generated low-degree fetal
chimeras in vivo. Interestingly, MASCs
appeared to share several features with
the recently reported epiblast stem cells
(EpiSCs), which are pluripotent stem
cells derived from murine postimplanta-
tion embryos (Lovell-Badge, 2007). These
features include colony morphology and
an epiblast-like gene expression pattern
that excludes several ESC markers. Like
MASCs, EpiSCs can generate teratomas
and show negligible chimera contribution,
demonstrating that these two cell types
share both molecular and functional char-
acteristics, suggestive of a similar pluripo-
tent state. Notably, Kanatsu-Shinohara
et al. also commented on the epiblast-
like morphology of emerging mGSC colo-4 Cell Stem Cell 5, July 2, 2009 ª2009 Elsevnies, and the gene expression data of
mGSCs seem to support an epiblast-like
signature of these cells (Kanatsu-Shino-
hara et al., 2004, 2008).
Different Pluripotent States
of Testis-Derived Stem Cells?
In summary, several groups have re-
ported the derivation of pluripotent stem
cells from murine and human testes,
which display different epigenetic, molec-
ular, and functional properties. Murine
pluripotent stem cells can exist in a variety
of distinct pluripotent states depending
on the stage of donor embryo, strain
background, and derivation conditions.
While the molecular and functional prop-
erties of previously described testis-
derived stem cell lines appear consistent
with an EpiSC-like pluripotent state, the
gPS cells reported here by Scho¨ler and
colleagues display morphological and
molecular characteristics akin to ESCs,
including their ability to generate germline
chimeras. It remains to be seen, however,
whether these differences reflect different
pluripotent states or result from different
culture conditions, strain backgrounds,
or reporter alleles, which are known to
influence the pluripotent state of murine
ESCs (Chou et al., 2008; Hanna et al.,
2009; Hochedlinger and Plath, 2009). For
example, the germ cell markers Stra8
and GPR125 may mark more differenti-
ated subpopulations of spermatogonia
compared with Oct4, which may identify
more primitive cells. The advances re-
ported by Ko and colleagues greatly facil-
itate further exploration of the influence of
genetic background and microenviron-
ment on the frequency and dynamicsier Inc.of converting restricted cells to pluripo-
tency.
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